Elucidata
Karan Tiwari started as an intern at Voltas Limited in 2014 and later joined SKF Group as a Graduate Engineering Trainee, Manufacturing Engineering. Karan worked as a Territory Manager and later progressed to Consultative Sales and Business Development, where they developed long-term performance-based partnerships across various industries. Karan joined Invest India as a Consultant Internship in 2021 and worked as a Chief Marketing Officer at PeaceX, responsible for creating innovative marketing strategies. Karan then worked as a Senior Account Executive at Whatfix, responsible for revenue generation and new logo acquisition, before joining Elucidata as a Senior Sales Development Manager in 2023. Karan pursued an MBA at the Indian Institute of Management, Kozhikode, from 2020 to 2022.
Karan Tiwari first attended Neerja Modi School from 2008-2010 where they completed their Class XIIth degree. Karan then studied at Vellore Institute of Technology from 2010-2014 and earned a Bachelor of Technology degree in Mechanical Engineering. In 2020, Karan Tiwari attended the Indian Institute of Management in Kozhikode and earned a Master of Business Administration degree with a field of study in Business Administration and Management.
Karan Tiwari has also obtained additional certifications throughout their education. Karan earned a certificate in Finance and Banking Fundamentals from Finitiatives Learning India Pvt Ltd. (FLIP) in 2020 and a certificate in Financial Markets from Shine Projects in 2020. Karan also obtained a Six Sigma Green Belt certification from SKF India in 2017, a Sales Excellence certification from SKF India in 2017, and a Project Training certificate from Voltas Limited in 2014. In 2013, they earned a certificate in Design Thinking Action Lab from NovoEd, and in 2012, they received a Certificate of Merit for F1 Race from Vellore Institute of Technology. Finally, in 2014, they received a certificate for Full Throttle RC Car Race from Mood Indigo IIT Bombay.
This person is not in any offices
Elucidata
5 followers
Elucidata offers 10x faster identification of therapeutic assets with high odds of success in the clinic. It has enabled the detection of multiple validated drug targets across immunology, oncology, and metabolic disorders. Elucidata supports discovery programs at Pfizer, Agios Pharmaceuticals, Genentech, and Yale and has 35+ research partners from premier biopharma companies and research labs.